SEC Form 4 · accession 0001387131-15-003566
Ohr Pharmaceutical Inc · OHRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Scott Slakter
Officer — Chief Executive Officer · Director
Period of report
Dec 7, 2015
Accepted (ET)
Dec 8, 2015 · 2:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001173281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Dec 7, 2015 | P | 100 | $4.13 | A | 506,246 | D | |
| Common Stock, par value $0.0001 per share | Dec 7, 2015 | P | 1,200 | $4.12 | A | 507,446 | D | |
| Common Stock, par value $0.0001 per share | Dec 7, 2015 | P | 100 | $4.10 | A | 507,546 | D | |
| Common Stock, par value $0.0001 per share | Dec 7, 2015 | P | 300 | $4.07 | A | 507,846 | D | |
| Common Stock, par value $0.0001 per share | Dec 7, 2015 | P | 300 | $4.05 | A | 508,146 | D | |
| Common Stock, par value $0.0001 per share | Dec 7, 2015 | P | 800 | $4.02 | A | 508,946 | D | |
| Common Stock, par value $0.0001 per share | Dec 7, 2015 | P | 200 | $4.00 | A | 509,146 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2015.